GRAND RAPIDS, Mich., Nov. 4, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that Rob Ball, CEO, will present at the upcoming Jefferies Global Healthcare Conference. The presentation will take place at 8:30 a.m. GMT / 3:30 a.m. EST on November 18, 2025. Event: Jefferies Global Healthcare Conference Date: Tuesday, November 18, 2025Time: 8:30 ...

Core Insights - Shoulder Innovations, Inc. has launched the InSet™ 70 Humeral Stem, expanding its I-Series product line, which initially included the InSet™ 95 launched in 2024 [1][2] Product Details - The InSet™ 70 is designed for both anatomic and reverse shoulder arthroplasty, addressing various clinical needs such as osteoarthritis, avascular necrosis, and irreparable cuff tears [2][3] - This new product offers excellent initial fixation and a simple workflow similar to the InSet™ 95, while providing bone-sparing utility, making it advantageous in shoulder care [3] Company Overview - Shoulder Innovations focuses on transforming the shoulder surgical care market with advanced implant systems and an ecosystem aimed at improving preoperative planning, implant design, and procedural efficiency [4]